Chronic Inflammation and Breast Cancer Recurrence

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2009 May 28

PMID 19470918

Citations 63

Authors

Steven W Cole

Affiliations

Soon will be listed here.

Citing Articles

Yoga Intervention and Inflammatory Homoeostasis in Breast Cancer Patients.

Kaje K, Dsilva F, Shetty P, Mohan R, Kumar S, Dsouza N Indian J Palliat Care. 2025; 31(1):1-7.

PMID: 40027973 PMC: 11866663. DOI: 10.25259/IJPC_181_2024.

Rare Cell Population Analysis in Early-Stage Breast Cancer Patients.

Schreier S, Budchart P, Borwornpinyo S, Adireklarpwong L, Chirappapha P, Triampo W Breast Cancer (Auckl). 2025; 19():11782234241310596.

PMID: 39803593 PMC: 11724413. DOI: 10.1177/11782234241310596.

Breast Cancer Local Recurrence Risk in Implant-Based Breast Reconstruction with Macrotexturized and Microtexturized Prosthesis: A Multicentric Retrospective Cohort Study.

Vinci V, Klinger F, Di Giuli R, Lisa A, Catania B, Vaccari S Indian J Plast Surg. 2024; 57(5):372-378.

PMID: 39552806 PMC: 11567768. DOI: 10.1055/s-0044-1787059.

Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study.

Artese A, Zhou X, Tometich D, Small B, Ahles T, Ahn J J Natl Cancer Inst. 2024; 116(12):2009-2021.

PMID: 39107910 PMC: 11630529. DOI: 10.1093/jnci/djae182.

Avanzando Caminos (Leading Pathways): design and procedures of the Hispanic/Latino Cancer Survivorship Study.

Penedo F, Moreno P, Pons M, Pinheiro P, Antoni M, Lopes G Am J Epidemiol. 2024; 193(7):940-950.

PMID: 38576195 PMC: 11466847. DOI: 10.1093/aje/kwae033.

References

Anderson W, Schairer C, Chen B, Hance K, Levine P . Epidemiology of inflammatory breast cancer (IBC). Breast Dis. 2006; 22:9-23. PMC: 2852616. DOI: 10.3233/bd-2006-22103. View

Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340(6):448-54. DOI: 10.1056/NEJM199902113400607. View

Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

Zhang G, Adachi I . Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 1999; 19(2B):1427-32. View

Mantovani A, Marchesi F, Porta C, Sica A, Allavena P . Inflammation and cancer: breast cancer as a prototype. Breast. 2007; 16 Suppl 2:S27-33. DOI: 10.1016/j.breast.2007.07.013. View

Ford D, Erlinger T . Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004; 164(9):1010-4. DOI: 10.1001/archinte.164.9.1010. View

Snoussi K, Strosberg A, Bouaouina N, Ben Ahmed S, Chouchane L . Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw. 2006; 16(4):253-60. View

Cushman M, Costantino J, Tracy R, Song K, Buckley L, Roberts J . Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect. Arterioscler Thromb Vasc Biol. 2001; 21(2):255-61. DOI: 10.1161/01.atv.21.2.255. View

Pepys M, Hirschfield G . C-reactive protein: a critical update. J Clin Invest. 2003; 111(12):1805-12. PMC: 161431. DOI: 10.1172/JCI18921. View

10.

Coussens L, Werb Z . Inflammation and cancer. Nature. 2002; 420(6917):860-7. PMC: 2803035. DOI: 10.1038/nature01322. View

11.

Siemes C, Visser L, Coebergh J, Splinter T, Witteman J, Uitterlinden A . C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006; 24(33):5216-22. DOI: 10.1200/JCO.2006.07.1381. View

12.

Timpson N, Lawlor D, Harbord R, Gaunt T, Day I, Palmer L . C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005; 366(9501):1954-9. DOI: 10.1016/S0140-6736(05)67786-0. View

13.

Salgado R, Junius S, Benoy I, van Dam P, Vermeulen P, Van Marck E . Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer. 2002; 103(5):642-6. DOI: 10.1002/ijc.10833. View

14.

Knupfer H, Preiss R . Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat. 2006; 102(2):129-35. DOI: 10.1007/s10549-006-9328-3. View

15.

Pierce B, Neuhouser M, Wener M, Bernstein L, Baumgartner R, Ballard-Barbash R . Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat. 2008; 114(1):155-67. PMC: 3523176. DOI: 10.1007/s10549-008-9985-5. View

16.

Williams M, Turkes A, Pearson D, Griffiths K, Blamey R . An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. Br J Cancer. 1990; 61(1):126-32. PMC: 1971340. DOI: 10.1038/bjc.1990.26. View

17.

Pierce B, Ballard-Barbash R, Bernstein L, Baumgartner R, Neuhouser M, Wener M . Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009; 27(21):3437-44. PMC: 2717751. DOI: 10.1200/JCO.2008.18.9068. View

18.

DeCensi A, Gandini S, Serrano D, Cazzaniga M, Pizzamiglio M, Maffini F . Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. J Clin Oncol. 2007; 25(27):4201-9. DOI: 10.1200/JCO.2006.09.4318. View

19.

Chiang A, Massague J . Molecular basis of metastasis. N Engl J Med. 2008; 359(26):2814-23. PMC: 4189180. DOI: 10.1056/NEJMra0805239. View

20.

Banks J, Marmot M, Oldfield Z, Smith J . Disease and disadvantage in the United States and in England. JAMA. 2006; 295(17):2037-45. DOI: 10.1001/jama.295.17.2037. View